Endpoints News ٢٩ يناير ٢٠٢٦ Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliff
Endpoints News ٢٨ يناير ٢٠٢٦ Round three of IRA negotiations is expected to be ‘manageable’ for pharma
Endpoints News ٢٨ يناير ٢٠٢٦ Lonza still intends to sell its capsules and health ingredients business
Endpoints News ٢٨ يناير ٢٠٢٦ FDA suspends Regenxbio gene therapy trials after patient developed brain tumor